Drug: |
AZD6244 plus Temsirolimus |
|||
---|---|---|---|---|
Trial: |
MEK Inhibitor AZD6244 With or Without Temsirolimus in Treating Patients With Metastatic, Recurrent, or Locally Advanced Soft Tissue Sarcoma That Cannot Be Removed By Surgery |
|||
Conditions: | Sarcoma | |||
Trial Status: |
Ongoing, but not recruiting |
City of Hope - Pasadena |
Principal Investigator: |
|
---|---|
Contact: |
Mark V. McNamara, MD 626-396-2900 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
City of Hope - Pasadena Website: |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.